Combined Effects of Segmental Vibrator With Neuromuscular Electrical Stimulation for Dorsiflexors on Lower Limb Function in Subacute Stroke

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Stroke is one of the world's leading causes of death and disability. It can cause a variety of motor disorders, such as apraxia, sensory deficits, abnormal muscle tone, inadequate weight transfer, lack of fine motor skills, incoordination, and balance deficit. These disorders can have a significant negative impact on a person's quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 60
Healthy Volunteers: f
View:

• Both male and female patients were included in the study.

• The age range of participants was between 45 and 60 years.

• Participants that were diagnosed with ischemic stroke patient.

• Participants had experienced sub-acute ischemic stroke, specifically 15 days to 12 weeks post-stroke.

• Montreal Cognitive Assessment scores falling within the range of 18-24 were necessary.

• Modified Ashworth scale scores had to be less than +1

• National Institutes of Health Stroke Scale (NIHSS) score falling within the range of 1 to 15 were necessary.

• Participants feel no pain from the vibrator.

• It was anticipated that participants would either be able to give informed consent or have a legal representative who could do so.

Locations
Other Locations
Pakistan
Jinnah Hospital
RECRUITING
Lahore
Contact Information
Primary
Aruba Saeed, Phd
arubasaeedpt@gmail.com
03344399403
Time Frame
Start Date: 2025-04-10
Estimated Completion Date: 2025-09-30
Participants
Target number of participants: 50
Treatments
Experimental: group A
Group A: Standard physical therapy and segmental vibrator on dorsiflexor muscle groups
Experimental: group B
Group B: Standard physical therapy and segmental vibrator + electrical stimulation on dorsiflexor muscle group
Related Therapeutic Areas
Sponsors
Leads: Riphah International University

This content was sourced from clinicaltrials.gov